Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410634 | SCV000487613 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2016-05-24 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411755 | SCV000487614 | likely pathogenic | Peroxisome biogenesis disorder 1B | 2016-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005055950 | SCV005716866 | pathogenic | Zellweger spectrum disorders | 2024-02-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu721Cysfs*19) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 371742). For these reasons, this variant has been classified as Pathogenic. |